ANNE REVIERE: Open Payments
NPI 1770891269 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 15 payments from 7 companies in 2025. Trend: 2023 $74 · 2024 $0 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $217 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
| Lundbeck LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $17 |
Products named: VRAYLAR, FANAPT, REXULTI, HETLIOZ, NP Thyroid 60, ARISTADA, ZURZUVAE.
Industry payments across TN — which companies pay providers there.
